Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

Burning Rock Biotech (BNR) Cost of Revenue (2019 - 2025)

Burning Rock Biotech has reported Cost of Revenue over the past 7 years, most recently at $4.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 20.86% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $19.1 million, down 10.18%, while the annual FY2025 figure was $23.6 million, 9.69% down from the prior year.
  • Cost of Revenue for Q4 2025 was $4.0 million at Burning Rock Biotech, down from $4.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $7.6 million in Q1 2022 and troughed at $4.0 million in Q4 2025.
  • A 5-year average of $5.7 million and a median of $5.7 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 66.95% in 2022 and later decreased 20.86% in 2025.
  • Year by year, Cost of Revenue stood at $6.6 million in 2021, then fell by 9.79% to $5.9 million in 2022, then increased by 1.89% to $6.1 million in 2023, then fell by 17.15% to $5.0 million in 2024, then dropped by 20.86% to $4.0 million in 2025.
  • Business Quant data shows Cost of Revenue for BNR at $4.0 million in Q4 2025, $4.6 million in Q3 2025, and $5.6 million in Q2 2025.